FDA delays public meeting for COVID-19 vaccine for children under 5 to review more data
WASHINGTON (AP) - U.S. regulators on Friday put the brakes on their push to speed Pfizer's COVID-19 to children under 5, creating major uncertainty about how soon the shots could b…
